Ai Vita Biomedical announced it raised $6.05 Million in an initial filing from an offering of $85 Million
Ai Vita Biomedical announced it raised $6.05 Million in an initial filing from an offering of $85 Million
08/30/22, 8:33 PM
Location
irvine
Money raised
$6.05 million
Industry
therapeutics
health care
biotechnology
Company Info
Location
18301 von karman ave., suite 130
irvine, california, united states
Additional Info
AIVITA Biomedical, Inc. is a biotech company specializing in innovative stem cell applications. Founded in 2016, the company utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline. AIVITA's cancer immunotherapy targets the seed of all cancers, tumor-initiating cells, with a unique pan-antigenic approach that targets all neoantigens specific to the patient's cancer. The company's patient-specific cancer treatments have shown great promise including eradicating tumors, without harmful side effects in melanoma, and renal cell cancer, and prolonging progression-free survival in glioblastoma. AIVITA's Vaccine Enabling Kit for infectious diseases is targeted to emerging nations enabling point-of-care vaccine production in minimally equipped facilities by minimally trained third-party technicians.